Indian Dermatology Online Journal
Published by Wolters Kluwer Health
ISSN : 2229-5178 eISSN : 2249-5673
Abbreviation : Indian Dermatol. Online J.
Aims & Scope
Indian Dermatology Online Journal (IDOJ) is a bimonthly open access print journal of Indian Association of Dermatologists, Venereologists and Leprologists (IADVL).
It is available as print and online editions.
It was introduced with main objective to showcase clinical dermatology from India and all over the world.
All submissions are subject to peer review by the editorial board and the referees in the appropriate speciality or areas of interest.
This journal welcomes articles from across the globe but specially encourages articles on pure clinical dermatology .
We aim to encourage writing and publishing in the fond hope of sensitising dermatologists in India and the rest of the world to the importance of documentation.
Keeping in mind the spirit of the journal and its raison d’etre of encouraging sharing of dermatology in India, this journal is steadily growing in its stature, contents and readership.
We invite you to showcase your writing, experiences and work in this journal that will exhibit great promise in terms of readability, teaching, learning and sharing dermatology in India and across the globe​
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 2 |
2024 | 1.90 |
Journal Rank
Year | Value |
---|---|
2024 | 10925 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 688 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.532 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 24 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Side-effects of topical steroids: A long overdue revisit
Citation: 281
Authors: Arijit, Meghana, Shyam, Koushik
-
Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review
Citation: 206
Authors: Rahul, AlokKumar
-
Nanocarriers and nanoparticles for skin care and dermatological treatments
Citation: 164
Authors: Sanjeev, Radhika, Sunita, Nidhi, Abhinav
-
The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive?
Citation: 122
Authors: Sunil, Shraddha
-
Current situation of leprosy in India and its future implications
Citation: 105
Authors: PNarasimha, Sujai